These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 6455822)

  • 21. Induction of antitumor immunity using bone marrow-generated dendritic cells.
    Porgador A; Snyder D; Gilboa E
    J Immunol; 1996 Apr; 156(8):2918-26. PubMed ID: 8609412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of levamisole on T lymphocyte colony formation by cells from bone marrow aspirates.
    Gordon MY
    Clin Exp Immunol; 1981 Aug; 45(2):365-70. PubMed ID: 6976244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the two-signal requirement for precursor cytolytic T lymphocyte activation using H-2Kk in liposomes.
    Herrmann SH; Weinberger O; Burakoff SJ; Mescher MF
    J Immunol; 1982 May; 128(5):1968-74. PubMed ID: 6801126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human natural killer cell development from bone marrow progenitors: analysis of phenotype, cytotoxicity and growth.
    Lotzová E; Savary CA
    Nat Immun; 1993; 12(4-5):209-17. PubMed ID: 8257827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The origin of cytotoxic T lymphocyte precursors (CTL-P): MHC-restricted and alloreactive CTL-P in the spleen during regeneration after a sublethal dose of cyclophosphamide (Cy).
    Sihvola M; Hurme M
    J Immunol; 1983 Mar; 130(3):1077-83. PubMed ID: 6600471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peptide from one of the alpha helical regions of H-2Kb can manipulate responses to the H-2Kb alloantigen in vitro and in vivo.
    Wood K; Bell Y; Morris P
    Transplant Proc; 1993 Feb; 25(1 Pt 1):481-2. PubMed ID: 8438387
    [No Abstract]   [Full Text] [Related]  

  • 27. Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype.
    Maccario R; Podestà M; Moretta A; Cometa A; Comoli P; Montagna D; Daudt L; Ibatici A; Piaggio G; Pozzi S; Frassoni F; Locatelli F
    Haematologica; 2005 Apr; 90(4):516-25. PubMed ID: 15820948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunosuppression of marrow B lymphocytes by administration of Corynebacterium parvum in mice.
    Jyonouchi H; Kincade PW; Good RA
    J Immunol; 1981 Dec; 127(6):2502-7. PubMed ID: 6457877
    [No Abstract]   [Full Text] [Related]  

  • 29. Bone marrow derived diffuse colonies: their cytotoxic potential, morphology, and antigenic phenotype.
    Claësson MH; Olsson L; Martinsen L; Brix-Poulsen P
    Exp Hematol; 1982 Sep; 10(8):708-21. PubMed ID: 7140870
    [No Abstract]   [Full Text] [Related]  

  • 30. Erythroid cells in immunoregulation: characterization of a novel suppressor factor.
    Seledtsova GV; Seledtsov VI; Samarin DM; Senyukov VV; Ivanova IP; Akimenko ZA; Tsyrlova IG; Wolpe SS; Kozlov VA
    Immunol Lett; 2004 May; 93(2-3):171-8. PubMed ID: 15158614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular interactions in the regulation of the cytolytic T-lymphocyte response: the effect of suboptimal antigen dose.
    Burakoff SJ; Weinberger O; Herrmann SH; Mescher MF
    Transplant Proc; 1981 Mar; 13(1 Pt 2):1039-41. PubMed ID: 6973854
    [No Abstract]   [Full Text] [Related]  

  • 32. Antigen presentation determines the fate of the T memory response in vivo after sublethal gamma-irradiation.
    Sechler JM; Hansal SA; Morris DI; McFarland HI; Rosenberg AS
    J Immunol; 1999 Nov; 163(9):4701-6. PubMed ID: 10528167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of potent mixed leukocyte reaction-stimulatory cells in human bone marrow. Putative differentiation stage of human blood dendritic cells.
    Egner W; McKenzie JL; Smith SM; Beard ME; Hart DN
    J Immunol; 1993 Apr; 150(7):3043-53. PubMed ID: 8454872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.
    Giorgini A; Noble A
    J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NKG2D and natural cytotoxicity receptors are involved in natural killer cell interaction with self-antigen presenting cells and stromal cells.
    Poggi A; Prevosto C; Zancolli M; Canevali P; Musso A; Zocchi MR
    Ann N Y Acad Sci; 2007 Aug; 1109():47-57. PubMed ID: 17785290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of immunosuppression by cyclosporin.
    Keown PA; Essery GL; Stiller CR; Sinclair NR; Mullen R; Ulan RA
    Transplant Proc; 1981 Mar; 13(1 Pt 1):386-9. PubMed ID: 6455795
    [No Abstract]   [Full Text] [Related]  

  • 37. Qualitative differences in the lymphocyte phytohemagglutinin (PHA) response between the bone marrow and other lymphoid organs.
    Press OW; Rosse C
    Cell Immunol; 1977 Jan; 28(1):206-17. PubMed ID: 832315
    [No Abstract]   [Full Text] [Related]  

  • 38. Augmentation of proliferation and generation of specific cytotoxic cells in human mixed lymphocyte culture reactions by colchicine.
    Suthanthiran M; Stenzel KH; Rubin AL; Novogrodsky A
    Cell Immunol; 1980 Mar; 50(2):379-91. PubMed ID: 6444547
    [No Abstract]   [Full Text] [Related]  

  • 39. [Post-angiographic thorotrastosis and chronic agranulocytosis: ultrastructural examination of the bone marrow (author's transl)].
    Oberling F; Lang JM; Fabre M; Liautaud M; Mayer G; Waitz R
    Nouv Rev Fr Hematol; 1973; 13(3):291-305. PubMed ID: 4270584
    [No Abstract]   [Full Text] [Related]  

  • 40. [In vitro induction of cytotoxicity mediated by macrophages (proceedings)].
    Lohmann-Matthes ML
    Minerva Med; 1977 Oct; 68(50):3432. PubMed ID: 927717
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.